FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Herpes virus-based vaccine shows promise in targeting tumors without side effects

2.

Dramatic Increase in Active Surveillance Use for Prostate Cancer

3.

Colon cancer and exercise: Can physical activity reprogram genes?

4.

Are ultramarathon runners really at increased risk of bowel cancer?

5.

Real-World EV Plus Pembro Success Seen in Urothelial Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot